Preferred Dental Technologies Inc. ("Company") Announces "PDT Wellness" Initiative and the Introduction of New Organic, ...

Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI, US OTC: PDTTF): Announces “PDT Wellness” Initiative and the Introduction of New Organic, Pharmaceutical Grade CBD Products for Dental Offices

Winnipeg, MB -- October 31, 2018 -- InvestorsHub NewsWire -- PreferredDental Technologies Inc. (PDTI), through its wholly ownedsubsidiary Preferred Dental Implant Corp. (PDIC), is pleased to announce theintroduction of "PDT Wellness", a line of products designed for dental offices and beyond; dedicatedto innovative health care for the patient. This new venture consists oflaunching a series of products composed of highest quality, organic,pharmaceutical grade cannabidiol (CBD) grown, harvested and manufactured in theUS. CBD is one of the non-intoxicating components of hemp, and one that hasindicated significant supplemental medicalbenefits.All "PDT Wellness" products are THC free and will be marketed wherepermitted following individual state and federal regulations.

The growing body of research surrounding the effectiveness of CBDassisting in providing some relief of pain and anxiety is incredibly promising.With this in mind, PDTI as part of its mission statement of providinginnovative solutions in the dental market has been keeping an eye on thisdeveloping field for some time. We are pleased to announce today theculmination of this project. PDIC has negotiated a turn-key supply operationincluding fulfilment center capable of delivering the highest quality pharmaceuticalgrade CBD to the dental market.Initialproduct suite includes soft gel capsules and sublingual tincture deliverymethods in a variety of dosage concentrations and we expect other products tofollow as we continue to grow.

The current opioid epidemic that has rocked the healthcare industry hasbrought further attention to the potential of CBD supplements,deemed as a safe alternative method to consider when addressing pain and otherpatient symptoms. This is particularly true in the dental space, whereaccording to many estimates, dentists prescribe 12% of all immediate releaseopioids in the US (including 50% of all opioids prescribed to adolescents),second only to family physicians (15%) according to FDA numbers. They are alsoone of the professional groups least likely to provide long term patientfollow-up on these prescriptions. Because of this, the American DentalAssociation has stated that, "dentists play a keyrole in addressing the opioid crisis" and this past summer,has been crafting new policy to better address this issue. The availability ofCBD as a treatment option in other health care sectors has already begun toshow signs of reducing the effects and use of opioids.

With the increasing interest in CBD as a supplement and alternativetreatment method, questions of product quality are a major concern for healthcare providers and these legitimate concerns are likely to increase. Healthcare professionals may feel hesitant to provide CBD options to patients becauseof unknownquality and source of supply. For this reason, PDIC through its "PDT Wellness" line is proud to announce that every case of ourproduct will contain a full lab report of the product contained within. All "PDT Wellness" products are:

Highquality, pharmaceutical grade CBD

Organicallygrown in the US

THC-Free

Fullspectrum (containing a range of accepted cannabinoids such as CBDa, CBG andterpenes for superior effect)

Nanoemulsion technology creates smaller particles for greater bioavailability andabsorption

Free of contaminants such as pesticides and heavy metals

This will provide "PDT Wellness" products with a longevity mostcompetitors lack. While others chase trends, PDIC aims to provide solutionsrequested by healthcare professionals, through individual consultation andsurveys of concerns, wants and needs.

We have been developing our sales team over the past several months andwe anticipate we will have further updates shortly specifically addressingprogress made. In addition to the EAS Series dental implant components, oursales representatives are excited to begin introducing CBD based products todentists and oral surgeons for their consideration.We are expecting product to be availablewithin three weeks' time.

PDTI President, Mr. Erik Siegmund stated, "Obviously we are incredibly excited to bring news of this development toour shareholders. Regardless of the skill of the dental professional, in thepublic eye a visit to the dentist is associated with stress and pain. Thegrowing research literature on CBD supplements as an available option toconsider in addressing these symptoms provides an alternative for preciselythese areas making it a natural fit. Additionally, the data on anti-inflammatory qualities of CBD to date isimpressive suggesting a strong role in post treatment healing.PDTI was founded on bringing innovative andpractical solutions to the dental industry. Our original EAS Series of dentalimplant components, our branching into digital 3D print solutions and now the "PDT Wellness" line of CBD products all embody this spirit, one whichwe plan to continue to grow as the company does. I would like to give thanks tothe efforts of our Advisors, Board members and all resource personnel we haveengaged with, for spearheading this initiative."

About PDTI
PreferredDental technologies Inc. (PDTI) has been established to advance development andcommercialization of various evolutionary and disruptive technologies in thedental implant industry.

MISSION - INNOVATIVE & PRACTICAL SOLUTIONSFOR THE DENTAL INDUSTRY

Visit: www.preferreddentalimplant.com
www.prefdent.com

Onbehalf of Preferred Dental Technologies Inc.
Erik Siegmund
ChiefExecutive Officer
Email: info@prefdent.com
Tel:204.691.3722
www.prefdent.com

This news release maycontain forward-looking information which is not comprised of historical facts.

Forward-looking informationinvolves risks, uncertainties and other factors that could cause actual events,results, performance, prospects and opportunities to differ materially fromthose expressed or implied by such forward-looking information. Forward-lookinginformation in this news release may include, but is not limited to, theCompany's objectives, goals or future plans. Factors that could cause actualresults to differ materially from such forward-looking information include, butare not limited to, those risks set out in the Company's public documents filedon SEDAR. Although the Company believes that the assumptions and factors usedin preparing the forward-looking information in this news release are reasonable,undue reliance should not be placed on such information, which only applies asof the date of this news release, and no assurance can be given that suchevents will occur in the disclosed time frames or at all. The Company disclaimsany intention or obligation to update or revise any forward-looking information,whether as a result of new information, future events or otherwise, other thanas required by law. Neither the Canadian Securities Exchange nor itsRegulations Services Provider (as that term is defined in the policies of TheCanadian Securities Exchange accepts responsibility for the adequacy oraccuracy of this release.

SOURCE: Preferred Dental Technologies Inc.